Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8344 |
CPTH2
|
Apoptosis; Histone Acetyltransferase | Apoptosis; Chromatin/Epigenetic |
CPTH2 是一种组蛋白乙酰基转移酶抑制剂。它选择性地抑制Gcn5对组蛋白 H3 的乙酰化,通过抑制乙酰转移酶p300 (KAT3B)诱导凋亡并降低透明细胞肾癌细胞系的侵袭性。 | |||
T3633 |
Crenigacestat
LY3039478 |
Gamma-secretase | Neuroscience; Proteases/Proteasome; Stem Cells |
Crenigacestat (LY3039478) 是一种口服具有活性的Notch 和γ-secretase 的抑制剂,其在多种肿瘤细胞中的IC50为 ∼1nM。 | |||
T77810 |
XPW1
|
CDK | Cell Cycle/Checkpoint |
XPW1 是一种新的强效和选择性 CDK9 抑制剂,具有抗肿瘤活性,转录抑制ccRCC细胞中的DNA修复程序。XPW1 可用于研究透明细胞肾细胞癌。 | |||
T16679 |
Belzutifan
PT2977,MK-6482 |
HIF | Angiogenesis; Chromatin/Epigenetic |
Belzutifan (MK-6482) 是具有口服活性的 HIF-2α选择性抑制剂,IC50为 9 nM。Belzutifan 具有提高的效力和改善的药代动力学特征。Belzutifan (MK-6482) 可以抑制透明细胞肾细胞癌。 | |||
T61442 | HIF-1/2α-IN-1 | ||
HIF-1/2α-IN-1, an orally active compound, functions as an inhibitor of HIF-2α. Its inhibitory effect on HIF-2α activity is significant, with an IC 50 value of 0.92 μM. Furthermore, HIF-1/2α-IN-1 has the ability to decrease HIF-1α levels. This compound is particularly valuable for research on clear cell renal cell carcinoma (ccRCC) [1]. |